drugset / Trial / NCT00110669

High-dose Prednisone in Duchenne Muscular Dystrophy

NCT00110669 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

This study will help to determine whether a high-dose weekly course of prednisone therapy is safer than and at least as effective as daily dose therapy for people with Duchenne muscular dystrophy (DMD). Boys who are enrolled in this study should not have taken carnitine, other amino acids, creatine, glutamine, Coenzyme Q10 or any herbal medicines within the last three months. There will be a two-visit screening to take place in one week to ensure a reproducible manual muscle test. The subject will then be randomized and put into either the daily or weekly regimen. The duration of the study is twelve 28-day treatment cycles (approximately 12 months) with follow-up visits at month one, three and then every three months.

Timeline

Start
2004-01
Primary completion
2007-12
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisone Other / unclassified 0.75 mg/kg —
Comparator Prednisone Other / unclassified 10 mg/kg —